Pasta Zinci Oxidaty may be available in the countries listed below.
Zinc Oxide is reported as an ingredient of Pasta Zinci Oxidaty in the following countries:
International Drug Name Search
Betaclox may be available in the countries listed below.
Dicloxacillin sodium salt (a derivative of Dicloxacillin) is reported as an ingredient of Betaclox in the following countries:
International Drug Name Search
Novosterol may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Prednisolone 21-acetate (a derivative of Prednisolone) is reported as an ingredient of Novosterol in the following countries:
International Drug Name Search
Bléomycine Bellon may be available in the countries listed below.
Bleomycin sulfate (a derivative of Bleomycin) is reported as an ingredient of Bléomycine Bellon in the following countries:
International Drug Name Search
New Lecicarbon may be available in the countries listed below.
Sodium Bicarbonate is reported as an ingredient of New Lecicarbon in the following countries:
Sodium Phosphate Monobasic anhydrous (a derivative of Sodium Phosphate) is reported as an ingredient of New Lecicarbon in the following countries:
International Drug Name Search
Piroxicam Hexal may be available in the countries listed below.
Piroxicam is reported as an ingredient of Piroxicam Hexal in the following countries:
International Drug Name Search
Heksolin may be available in the countries listed below.
Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Heksolin in the following countries:
International Drug Name Search
Gadovist may be available in the countries listed below.
Gadobutrol is reported as an ingredient of Gadovist in the following countries:
International Drug Name Search
Adcirca is a brand name of tadalafil, approved by the FDA in the following formulation(s):
No. There is currently no therapeutically equivalent version of Adcirca available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Adcirca. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.
Atropine Faure may be available in the countries listed below.
Atropine sulfate (a derivative of Atropine) is reported as an ingredient of Atropine Faure in the following countries:
International Drug Name Search
Verbital may be available in the countries listed below.
Bezafibrate is reported as an ingredient of Verbital in the following countries:
International Drug Name Search
Dycon may be available in the countries listed below.
Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Dycon in the following countries:
International Drug Name Search
Dinaflex may be available in the countries listed below.
Glucosamine sulfate (a derivative of Glucosamine) is reported as an ingredient of Dinaflex in the following countries:
International Drug Name Search
Nitrepress may be available in the countries listed below.
Nitrendipine is reported as an ingredient of Nitrepress in the following countries:
International Drug Name Search
Generic Name: benzoyl peroxide topical (BEN zoyl per OX ide)
Brand Names: Acne Treatment, Acne-Clear, Benzac AC, Benzac W, Benzashave 10, Benzashave 5, BenzEFoam, Benziq, Benziq Wash, BPO Foaming Cloths, Brevoxyl, Brevoxyl Acne Wash Kit, Brevoxyl-4 Creamy Wash Complete Pack, Brevoxyl-8 Creamy Wash Complete Pack, Breze, Clearplex, Clearskin, Clinac BPO, Desquam-E, Desquam-X 10, Desquam-X 5, Desquam-X Wash, Fostex Bar 10%, Fostex Gel 10%, Fostex Wash 10%, Inova, Lavoclen-4, Lavoclen-8, Loroxide, NeoBenz Micro, Neutrogena Acne Mask, Neutrogena On Spot Acne Treatment, Oscion, Oscion Cleanser, Oxy 10 Balance, Oxy Balance, Oxy Daily Wash Chill Factor, Oxy-10, Pacnex, PanOxyl, Panoxyl 10, Panoxyl 5, Panoxyl Aqua Gel, PanOxyl Maximum Strength Foaming Acne Wash, Persa-Gel, Seba-Gel, SoluCLENZ Rx, Triaz, Triaz Cleanser, Zaclir
Benzoyl peroxide has an antibacterial effect. It also has a mild drying effect, which allows excess oils and dirt to be easily washed away from the skin.
Benzoyl peroxide topical (for the skin) is used to treat acne.
Benzoyl peroxide topical may also be used for purposes not listed in this medication guide.
There are many brands and forms of benzoyl peroxide available and not all brands are listed on this leaflet.
Use this medication exactly as directed on the label, or as prescribed by your doctor. Do not use it in larger amounts or for longer than recommended.
Avoid using skin products that can cause irritation, such as harsh soaps, shampoos, or skin cleansers, hair coloring or permanent chemicals, hair removers or waxes, or skin products with alcohol, spices, astringents, or lime. Do not use other medicated skin products unless your doctor has told you to.
Benzoyl peroxide may bleach hair or fabrics. Avoid allowing this medication to come into contact with your hair or clothing.
It may take several weeks before your symptoms improve. Keep using the medication as directed and tell your doctor if your symptoms do not improve.
Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended.
Clean and pat dry the skin to be treated. Apply benzoyl peroxide in a thin layer and rub in gently.
Benzoyl peroxide topical is usually applied one to three times daily. Follow your doctor's instructions.
Benzoyl peroxide may bleach hair or fabrics. Avoid allowing this medication to come into contact with your hair or clothing.
It may take several weeks before your symptoms improve. Keep using the medication as directed and tell your doctor if your symptoms do not improve.
Use the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra medicine to make up the missed dose.
Avoid using skin products that can cause irritation, such as harsh soaps, shampoos, or skin cleansers, hair coloring or permanent chemicals, hair removers or waxes, or skin products with alcohol, spices, astringents, or lime. Do not use other medicated skin products unless your doctor has told you to.
Avoid using sunscreen containing PABA on the same skin treated with benzoyl peroxide, or skin discoloration may occur.
Less serious side effects may include:
mild stinging or burning;
itching or tingly feeling;
skin dryness, peeling, or flaking; or
redness or other irritation.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
It is not likely that other drugs you take orally or inject will have an effect on topically applied benzoyl peroxide topical. But many drugs can interact with each other. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
See also: Desquam-X 5 side effects (in more detail)
Meriol may be available in the countries listed below.
Methandriol is reported as an ingredient of Meriol in the following countries:
International Drug Name Search
Baro-Cat is a banana-pineapple flavored ready-to-use barium sulfate suspension for use as an aid for computed tomography of the gastrointestinal tract.
The contrast medium contains 1.5% w/w (w/v) barium sulfate USP, with sorbitol, simethicone, suspending agent, potassium sorbate, citric acid, flavoring, saccharin sodium and water. Barium sulfate has the empirical formula BaSO4.
Baro-Cat is indicated for use as a diagnostic aid (contrast medium) for computed tomography of the gastrointestinal tract.
Barium sulfate products are contraindicated in patients with known or suspected obstruction of the colon, known or suspected gastrointestinal tract perforation, suspected tracheoesophageal fistula, obstructing lesions of the small intestine, pyloric stenosis inflammation or neoplastic lesions of the rectum, recent rectal biopsy, or known hypersensitivity to barium sulfate formulations.
Barium sulfate suspensions should not be used for infants with swallowing disorders or for newborns with complete duodenal or jejunal obstruction or when distal small bowel or colon obstruction is suspected. Barium sulfate suspension is not recommended for very small preterm infants and young babies requiring small volumes of contrast media or for infants and young children when there is a possibility of leakage from the gastrointestinal tract, such as necrotizing enterocolitis, unexplained pneumoperitoneum, gasless abdomen, other bowel perforation, esophageal perforation or post operative anastomosis.
Known hypersensitivity or allergy to latex is a contraindication for the use of balloon retention enema tips containing latex. The use of a retention cuff enema tip is not necessary or desirable in patients with normal sphincter tone. The presence of adequate sphincter tone can be judged by preliminary rectal digital examination.
Diagnostic procedures which involve the use of radiopaque contrast agents should be carried out under the direction of personnel with the requisite training and with a thorough knowledge of the particular procedure to be performed. A history of bronchial asthma, atopy, as evidenced by hay fever and eczema, a family history of allergy, or a previous reaction to a contrast agent warrant special attention. Caution should be exercised with the use of radiopaque media in severely debilitated patients and in those with marked hypertension or advanced cardiac disease.
Anaphylactic and allergic reactions have been reported during double contrast examinations in which glucagon has been used.
An increased risk of perforation has been reported in neonates with intussusception. In patients with cystic fibrosis or blind loops of the bowel or ileus, there is a risk of inspissation leading to partial or complete obstruction.
In neonates and infants with motility disorders such as Hirschsprung’s Disease, retention of large amounts of barium sulfate suspension may result in absorption of water from the suspension and fluid overload. The addition of small amounts of salt to the barium sulfate suspension has been reported to reduce the problem.
Ingestion of barium sulfate suspension is not recommended in patients with a history of food aspiration. If barium sulfate suspension is aspirated into the larynx, further administration of the suspension should be immediately discontinued.
Patient preparation for diagnostic gastrointestinal examinations frequently requires cathartics and a liquid diet. The various preparations can result in water loss for the patient. Patients should be rehydrated quickly following a barium sulfate suspension examination of the gastrointestinal tract. In patients with reduced colon motility, saline cathartics may be required after the barium sulfate suspension enema. Saline cathartics are recommended on a routine basis in patients with a history of constipation unless clinically contraindicated.
Where enema tips are used, care must be taken during insertion into the patient, since forceful or too deep insertion may cause tearing or perforation of the rectum. Insertion of an enema tip should be done only after digital examination by qualified medical personnel. When balloon retention tips are used, care should be taken to avoid overinflation of the balloon, since overfilling or asymmetrical filling may cause displacement of the tip. Such a displacement can lead to rectal perforation or barium sulfate granulomas. Inflation of the balloon should be done under fluoroscopic control by qualified medical personnel. Do not unnecessarily move the enema tip once inserted.
A specially designed enema tip is required for a barium sulfate suspension examination of a colostomy patient.
Intubation of an enteroclysis catheter should be done by qualified medical personnel. Perforation of the duodenum has been reported.
Because of reported anaphylactoid reactions to latex, the use of non-latex gloves during the procedure should be considered.
The radiographic contrast agents used for examination of children do not differ substantially from those used for adults. The variation in physical sizes of pediatric patients requires more thorough attention to individualizing dosage. The volume of barium sulfate suspension and the barium sulfate content required will also depend upon the technique used and the clinical need.
Adverse reactions accompanying the use of barium sulfate formulations are infrequent and usually mild, though severe reactions (approximately 1 in 500,000) and fatalities (approximately 1 in 2,000,000) have occurred. Procedural complications are rare, but may include aspiration pneumonitis, barium sulfate impaction, granuloma formation, intravasation, embolization and peritonitis following intestinal perforation, vasovagal and syncopal episodes, and fatalities. EKG changes have been shown to occur following or during barium sulfate suspension enemas. It is of the utmost importance to be completely prepared to treat any such occurrence.
Due to the increased likelihood of allergic reactions in atopic patients, a complete history of known and suspected allergies as well as allergic-like symptoms, such as rhinitis, bronchial asthma, eczema and urticaria, must be obtained prior to any medical procedure.
Aspiration of large amounts of barium sulfate suspension may cause pneumonitis or nodular granulomas of interstitial lung tissues and lymph nodes; asphyxiation and death have been reported.
Transient bacteremia, beginning almost immediately and lasting up to 15 minutes, may also occur during rectal administration of barium sulfate suspension, and rarely septicemia has been reported.
A rare mild allergic reaction would most likely be generalized pruritis, erythema or urticaria (approximately 1 in 100,000 reactions). Such reactions will often respond to an antihistamine. More serious reactions (approximately 1 in 500,000) may result in laryngeal edema, bronchospasm or hypotension.
Severe reactions which may require emergency measures are often characterized by peripheral vasodilation, hypotension, reflex tachycardia, dyspnea, bronchospasm, agitation, confusion and cyanosis, progressing to unconsciousness. Treatment should be initiated immediately according to established standard of care.
Apprehensive patients may develop weakness, pallor, tinnitus, diaphoresis and bradycardia following the administration of any diagnostic agent. Such reactions are usually non-allergic in nature.
Allergic reactions to the enema accessories, in particular to retention catheters (tips) with latex cuffs, can occur. Such reactions could occur immediately and result in the previously mentioned acute allergic-like responses or might be delayed in appearance and result in a contact dermatitis. Known atopic patients, particularly those with a history of asthma or eczema, should be evaluated for alternative methods of administration in order to avoid these adverse reactions. These plastic/rubber accessories are disposable, single-use devices that must not be reused or left in the body cavity for an extended period of time.
The following adverse experiences have been reported in patients receiving products containing barium sulfate. These adverse experiences are listed alphabetically: abdominal cramping, abdominal pain, diarrhea, fever, foreign body trauma relating to procedural complications, headache, laryngeal burning and irritation, leukocytosis, procedural site reactions, rash, and vomiting.
The patient should drink 300 mL of ready-to-use Baro-Cat approximately 2 hours before the CT scan and an additional 300 mL approximately 15 minutes prior to examination.
If rapid upper gastrointestinal tract transit is desired, administer the product chilled.
The patient should drink 300 mL the night preceding the examination, 300 mL two hours prior to the examination and 300 mL approximately 15 minutes prior to examination.
The quantity of suspension used and the barium sulfate concentration will depend upon patient size, technique used and clinical need.
For single patient use only. Properly discard unused portion.
Catalog No. 169110. NDC 68240-622-03. 300 mL (10 fl. oz.) bottle; twenty-four (24) bottles with straws per case.
Catalog No. 169130. NDC 68240-622-09. 900 mL (30 fl. oz.) bottle; twelve (12) bottles per case.
Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F). Protect from freezing.
Shake well before using.
Baro-Cat is a trademark of Mallinckrodt Inc. or its subsidiaries.
Made in Mexico
Manufactured by:
Mallinckrodt Inc.
St. Louis, MO 63042 USA
www.Mallinckrodt.com
MID 1295065 Rev 03/2009
tyco
Healthcare
Mallinckrodt
L A F A Y E T T E
Baro-Cat™
BARIUM SULFATE
SUSPENSION
CT CONTRAST / G.I. EXAMS
Rx only
NDC 68240-622-09
Catalog No. 169130
A banana-pineapple flavored, ready-to-use, 1.5% w/w (w/v) barium sulfate suspension USP, for use as an aid for computed tomography of the gastrointestinal tract.
Contents: Barium sulfate USP, sorbitol, simethicone, suspending agent, potassium sorbate, citric acid, flavoring, saccharin sodium and water.
Contraindications: Do not use in patients with suspected gastrointestinal tract perforation or known hypersensitivity to barium sulfate formulations.
Dosage and Administration: See package insert for complete instructions. Shake well before using.
For single patient use only. Properly discard unused portion.
Storage: Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F). Protect from freezing.
Net Contents: 900 mL (30 fl. oz.)
Made in Mexico
Manufactured by Mallinckrodt Inc.
St. Louis, MO 63042 USA
www.Mallinckrodt.com
MID 1304663
Rev 03/2009
O3™ ANTIMICROBIAL TECHNOLOGY
tyco/Healthcare
MALLINCKRODT
| Baro-Cat barium sulfate suspension | ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| Marketing Information | |||
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| unapproved drug other | 06/01/2009 | 03/31/2011 | |
| Labeler - Mallinckrodt Inc. (810407189) |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| Mallinckrodt Medical, S.A. de C.V. | 810407189 | analysis, manufacture | |
Sparlox may be available in the countries listed below.
Sparfloxacin is reported as an ingredient of Sparlox in the following countries:
International Drug Name Search
Palio may be available in the countries listed below.
Pantoprazole is reported as an ingredient of Palio in the following countries:
International Drug Name Search
Calcitriolo Teva may be available in the countries listed below.
Calcitriol is reported as an ingredient of Calcitriolo Teva in the following countries:
International Drug Name Search
Oranvital may be available in the countries listed below.
Ascorbic Acid is reported as an ingredient of Oranvital in the following countries:
International Drug Name Search
Anexa may be available in the countries listed below.
Amlodipine besilate (a derivative of Amlodipine) is reported as an ingredient of Anexa in the following countries:
International Drug Name Search
Glorixone may be available in the countries listed below.
Ceftriaxone disodium salt (a derivative of Ceftriaxone) is reported as an ingredient of Glorixone in the following countries:
International Drug Name Search
Alprazolam Winthrop may be available in the countries listed below.
Alprazolam is reported as an ingredient of Alprazolam Winthrop in the following countries:
International Drug Name Search
Penticillin may be available in the countries listed below.
Piperacillin sodium salt (a derivative of Piperacillin) is reported as an ingredient of Penticillin in the following countries:
International Drug Name Search
Methotrexat Hexal may be available in the countries listed below.
Methotrexate sodium salt (a derivative of Methotrexate) is reported as an ingredient of Methotrexat Hexal in the following countries:
International Drug Name Search
Generic Name: desoximetasone (Topical application route)
des-ox-i-MET-a-sone
In the U.S.
In Canada
Available Dosage Forms:
Therapeutic Class: Corticosteroid, Strong
Pharmacologic Class: Adrenal Glucocorticoid
Desoximetasone topical is used to help relieve redness, itching, swelling, or other discomfort caused by skin conditions. This medicine is a corticosteroid (cortisone-like medicine or steroid).
This medicine is available only with your doctor's prescription.
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of desoximetasone in children 10 years of age or older. However, because of this medicine's toxicity, it should be used with caution. Children and teenagers who must use this medicine should be checked often by their doctor since desoximetasone topical may be absorbed through the skin and can affect growth or cause other unwanted effects. Safety and efficacy have not been established in children younger than 10 years of age.
No information is available on the relationship of age to the effects of desoximetasone topical in geriatric patients.
| Pregnancy Category | Explanation | |
|---|---|---|
| All Trimesters | C | Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women. |
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:
This section provides information on the proper use of a number of products that contain desoximetasone. It may not be specific to Desoxi. Please read with care.
Use this medicine exactly as directed by your doctor. Do not use it for any other condition without first checking with your doctor. This medicine may cause unwanted effects if it is used too much, because more of it is absorbed into the body through the skin.
Wash your hands with soap and water before and after using this medicine.
Be very careful not to get this medicine in your eyes. Wash your hands after using your finger to apply the medicine. If you accidentally get this medicine in your eyes, flush them with water.
Apply a thin layer of this medicine to the affected area of the skin. Rub it in gently.
Unless otherwise directed by your doctor, do not apply this medicine to open wounds, burns, or broken or inflamed skin.
This medicine should only be used for problems being treated by your doctor. Check with your doctor before using it for other problems, especially if you think that an infection may be present. This medicine should not be used to treat certain kinds of skin infections or serious problems, such as severe burns.
Do not bandage or otherwise wrap the skin being treated unless directed to do so by your doctor.
If your doctor has ordered an occlusive dressing (airtight covering, such as kitchen plastic wrap or a special patch) to be applied over this medicine, make sure you know how to apply it. Since occlusive dressings increase the amount of medicine absorbed through your skin and the possibility of side effects, use them only as directed. If you have any questions about this, check with your doctor.
The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
If you miss a dose of this medicine, apply it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
Ask your healthcare professional how you should dispose of any medicine you do not use.
It is very important that your doctor check your or your child's progress at regular visits for any problems or unwanted effects that may be caused by this medicine.
If your symptoms do not improve within a few days, or if it become worse, check with your doctor.
After applying this medicine to the skin of your child, watch the child carefully to make sure that he or she does not get any of the medicine in the eyes or mouth. This medicine can cause serious side effects, especially in children, if it gets into the mouth and is swallowed.
Using too much of this medicine or using it for a long time may increase your risk of having adrenal gland problems. The risk is greater for children and for patients who use large amounts for a long time. Talk to your doctor if you or your child have more than one of these symptoms while you are using this medicine: blurred vision; dizziness or fainting; fast, irregular, or pounding heartbeat; increased thirst or urination; irritability; or unusual tiredness or weakness.
Stop using this medicine and check with your doctor right away if you or your child have a skin rash, burning, stinging, swelling, or irritation on the skin.
Avoid using tight-fitting diapers or plastic pants on a child if this medicine is being used on the child's diaper area. Plastic pants and tight-fitting diapers may increase the chance of absorption of the medicine through the skin and the chance of side effects.
Do not use cosmetics or other skin care products on the treated skin areas.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
See also: Desoxi side effects (in more detail)
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
Metformax may be available in the countries listed below.
Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Metformax in the following countries:
International Drug Name Search
Flutamide Fidia may be available in the countries listed below.
Flutamide is reported as an ingredient of Flutamide Fidia in the following countries:
International Drug Name Search
Clinical studies have shown Darbepoetin Alfa (Albumin) to increase the risk of serious side effects (eg, blood clots, stroke, heart attack, heart failure) and death in some cases. It has also been shown to increase the risk of tumor growth in patients with advanced cancer. Talk with your doctor about the risks and benefits of using Darbepoetin Alfa (Albumin). Do not use more than the recommended dose without checking with your doctor.
Treating anemia in patients with chronic kidney failure or certain types of cancers. It may also be used for other conditions as determined by your doctor.
Darbepoetin Alfa (Albumin) is similar to the natural protein human erythropoietin. It works by stimulating the bone marrow to produce more red blood cells. An increased number of red blood cells may reduce symptoms of anemia.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Darbepoetin Alfa (Albumin). Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Darbepoetin Alfa (Albumin). Tell your health care provider if you are taking any other medicines.
Ask your health care provider if Darbepoetin Alfa (Albumin) may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Darbepoetin Alfa (Albumin) as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Darbepoetin Alfa (Albumin).
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Constipation; cough; diarrhea; dizziness; headache; muscle, joint, back, or stomach pain; nausea or vomiting; pain, swelling, irritation, redness, or bruising at the injection site; unusual tiredness or weakness.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); blurred vision or vision changes; chest pain; confusion; fainting; fast or irregular heartbeat; flu-like symptoms (chills, fever, sore throat); one-sided weakness; redness, tenderness, or swelling of the calf; seizures; severe diarrhea, dizziness, headache, stomach pain, or vomiting; severe or persistent tiredness or weakness; slurred speech; sudden pain or numbness of an arm or leg; sudden shortness of breath; swelling of the arms or legs.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Darbepoetin Alfa (Albumin) side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.
Store Darbepoetin Alfa (Albumin) in the refrigerator, between 36 and 46 degrees F (2 and 8 degrees C). Do not freeze. Protect from light. Do not use past the expiration date on the vial or prefilled syringe. When traveling, transport Darbepoetin Alfa (Albumin) in the original carton in a cool carrier with a coolant, such as blue ice. To avoid freezing, be sure the medicine does not touch the coolant. Once you arrive, place the medicine in the refrigerator as soon as possible. Keep Darbepoetin Alfa (Albumin) out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Darbepoetin Alfa (Albumin). If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Intrasite Applipak may be available in the countries listed below.
Carmellose is reported as an ingredient of Intrasite Applipak in the following countries:
International Drug Name Search
Metoc may be available in the countries listed below.
Metoclopramide dihydrochloride (a derivative of Metoclopramide) is reported as an ingredient of Metoc in the following countries:
International Drug Name Search
Risopent may be available in the countries listed below.
Clenbuterol hydrochloride (a derivative of Clenbuterol) is reported as an ingredient of Risopent in the following countries:
International Drug Name Search
Bioval may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Chlorocresol is reported as an ingredient of Bioval in the following countries:
Chloroxylenol is reported as an ingredient of Bioval in the following countries:
International Drug Name Search
In the US, Vasocon-A is a member of the drug class ophthalmic antihistamines and decongestants.
Antazoline phosphate (a derivative of Antazoline) is reported as an ingredient of Vasocon-A in the following countries:
Naphazoline hydrochloride (a derivative of Naphazoline) is reported as an ingredient of Vasocon-A in the following countries:
International Drug Name Search
Pasrin may be available in the countries listed below.
Buspirone hydrochloride (a derivative of Buspirone) is reported as an ingredient of Pasrin in the following countries:
International Drug Name Search
Managing certain conditions caused by high or low parathyroid hormone levels. It is used to manage low blood calcium levels in patients who are on chronic kidney dialysis. It may also be used for other conditions as determined by your doctor.
Rocaltrol Solution is a form of vitamin D. It works by promoting proper absorption and use of calcium and phosphate by the body in normal bone development and maintenance.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Rocaltrol Solution. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Rocaltrol Solution. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Rocaltrol Solution may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Rocaltrol Solution as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Rocaltrol Solution.
All medicines may cause side effects, but many people have no, or minor, side effects. When used in small doses, no COMMON side effects have been reported with this product. Seek medical attention right away if any of these SEVERE side effects occur:
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); bizarre behavior; bone pain; constipation; decreased sex drive; diarrhea; difficult or painful urination; dizziness; drowsiness; dry mouth; eye redness or irritation; fever; flushing; frequent urination; headache; increased body temperature; increased thirst; irregular heartbeat; loss of appetite; mental or mood changes; metallic taste; muscle pain; nausea; runny nose; sensitivity of the eyes to sunlight; stomach pain or cramps; unexplained weight loss; unusual thinking; vomiting; weakness.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Rocaltrol side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include dizziness; headache; irregular heartbeat; loss of appetite; mental or mood changes; nausea; stomach pain or cramps; vomiting; weakness.
Store Rocaltrol Solution in a tightly closed container between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Rocaltrol Solution out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Rocaltrol Solution. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.